Cicatricial Alopecia Research Foundation Meeting, May 2016: Progress Towards the Diagnosis, Treatment, and Cure of Primary Cicatricial Alopecias

    January 2018 in “ Experimental Dermatology
    John P. Sundberg, Maria Hordinsky, Wilma F. Bergfeld, Yolanda M. Lenzy, Amy J. McMichael, Angela M. Christiano, Tracy L. McGregor, Kurt S. Stenn, Raja K Sivamani, C. Herbert Pratt, Lloyd E. King
    Image of study
    TLDR The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.
    The Cicatricial Alopecia Research Foundation meeting in May 2016 addressed primary cicatricial alopecias (PCAs), diseases causing irreversible hair follicle destruction and scarring. Over 100 attendees reviewed current knowledge and set research priorities, focusing on lichen planopilaris (LPP), frontal fibrosing alopecia (FFA), and central centrifugal cicatricial alopecia (CCCA). The report emphasized the challenges in diagnosing PCAs due to scarring by the time patients seek treatment and discussed new technologies like transcriptome and lipidome analysis for understanding disease pathogenesis. It also highlighted the use of mouse models, clinicopathological correlations, dermoscopy, and biopsy in PCA research. The document noted the unknown etiopathogenesis of PCAs but suggested potential causes such as loss of immune privilege, inflammatory responses, and genetic factors. It also mentioned the use of large biorepositories for epidemiological and genetic research, including GWAS and PheWAS, and the role of sebaceous gland dysfunction in some PCAs. The meeting set research goals for standardized sample collection, gene expression studies, computational analysis for drug discovery, and microbiome studies, while acknowledging the limitations of animal models in replicating human PCAs.
    Discuss this study in the Community →

    Research cited in this study

    34 / 34 results

    Related Community Posts Join

    6 / 290 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  134 upvotes 8 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community We need to keep these snake oil companies accountable.

      in Treatment  121 upvotes 6 months ago
      Biotin is being misleadingly marketed as a primary treatment for androgenic alopecia, overshadowing more effective treatments like finasteride and minoxidil. There is a call for increased awareness and accountability to prevent misinformation.

    Related Research

    8 / 8 results